Conduct the bling III PK/PD sub-study, which is a prospective, observational, multinational sub-study within the parent bling III RCT.

Ended Definitive Contract Awarded Last action

Contract number
75F40121C00126
Awardee
Awarding agency
Obligated
$300,851

Award facts

Opportunity
Contract value 100% obligated
$300,851.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Cost No Fee
Place of performance
Calverton, MD 20705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$87,496
Other Administrative Action P00006 · The purpose of this modification is to change the buyer for invoicing purposes. All other terms and conditions remain unchanged. $0
Other Administrative Action P00005 · The purpose of this modification is to revised the deliverable schedule. $0
Other Administrative Action P00004 · The purpose of this modification is to revise the allocation of budgeted items. $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 · The purpose of this modification is to incorporate hhsar 352.232-71, electronic submission of payment requests (FEB 2022) and FDA electronic invoicing and… $0
Other Administrative Action P00001 $0
Original award $388,347

About this award

The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract worth $300,851.00 to The University of Queensland, a non-profit educational institution, to conduct the BLING III PK/PD sub-study, a prospective, observational, multinational sub-study within the parent BLING III randomized controlled trial. The contract does not use a set-aside designation. The original solicitation was issued through the FDA's Broad Agency Announcement for Advanced Regulatory Science, which seeks research and development proposals across multiple areas of regulatory science to support the agency's mission. As a prime contractor, The University of Queensland has received over $7 million in federal contracts from agencies such as the U.S. Army, Navy, and FDA to provide research, investigative, and development services.

Quick answers

Who was awarded contract 75F40121C00126?

75F40121C00126 was awarded to The University Of Queensland by Food and Drug Administration (Department of Health and Human Services) on September 24, 2021.

How much is contract 75F40121C00126 worth?

The government has obligated $300,851 on 75F40121C00126.

Was contract 75F40121C00126 competed?

The extent of competition for 75F40121C00126 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award